Page last updated: 2024-10-27

flufenamic acid and Grippe

flufenamic acid has been researched along with Grippe in 1 studies

Flufenamic Acid: An anthranilic acid derivative with analgesic, anti-inflammatory, and antipyretic properties. It is used in musculoskeletal and joint disorders and administered by mouth and topically. (From Martindale, The Extra Pharmacopoeia, 30th ed, p16)
flufenamic acid : An aromatic amino acid consisting of anthranilic acid carrying an N-(trifluoromethyl)phenyl substituent. An analgesic and anti-inflammatory, it is used in rheumatic disorders.

Research Excerpts

ExcerptRelevanceReference
"Seasonal influenza virus remains a common cause of mortality despite the use of neuraminidase inhibitors."1.48Triple combination of FDA-approved drugs including flufenamic acid, clarithromycin and zanamivir improves survival of severe influenza in mice. ( Chan, KH; Hung, IFN; Kao, RYT; Lee, ACY; Li, C; To, KKW; Yuen, KY; Zhang, AJX; Zhang, RR; Zhu, H, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, ACY1
To, KKW1
Zhang, AJX1
Zhu, H1
Li, C1
Zhang, RR1
Hung, IFN1
Kao, RYT1
Chan, KH1
Yuen, KY1

Other Studies

1 other study available for flufenamic acid and Grippe

ArticleYear
Triple combination of FDA-approved drugs including flufenamic acid, clarithromycin and zanamivir improves survival of severe influenza in mice.
    Archives of virology, 2018, Volume: 163, Issue:9

    Topics: Animals; Antiviral Agents; Clarithromycin; Drug Approval; Drug Evaluation, Preclinical; Drug Therapy

2018